For example, in type 2 diabetes mellitus (T2DM), miR-125a-5p was been reported to ameliorate hepatic glycolipid metabolism disorder through targeting signal transducer and activator of transcription 3 (STAT3)30. This evidence concerns the gene STAT3 and metabolic disease.